Literature DB >> 26505653

Dysregulated co-stimulatory molecule expression in a Sjögren's syndrome mouse model with potential implications by microRNA-146a.

Adrienne E Gauna1, Yun-Jong Park2, Gautam Nayar3, Marelys Onate4, Jun-o Jin5, Carol M Stewart6, Qing Yu7, Seunghee Cha8.   

Abstract

Sjögren's syndrome (SjS) is an autoimmune condition that primarily affects salivary and lacrimal glands, causing loss of secretion. We have previously shown that microRNA-146a (miR-146a) is over-expressed in the salivary glands and peripheral blood mononuclear cells (PBMC) of SjS-prone mice (C57BL/6.NOD-Aec1Aec2, B6DC) and in PBMC of SjS patients. The purpose of this research was to identify a target molecule of miR-146a and identify subpopulations of cells affected by altered miR-146a in the salivary glands of SjS-prone mice. In silico analyses identified costimulatory molecule CD80 as a potential target of miR-146a. Luciferase assay of the human CD80 3'untranslated region demonstrated miR-146a directly inhibited CD80 protein expression as indicated by reduced luciferase reporter expression and an examination of B6DC salivary glands revealed a reduction in CD80 protein. More interestingly, the specific reduction in CD80 protein was detected from the salivary gland epithelial cell population and in interstitial dendritic cells in the glands as well. The reduction in CD80 protein levels in salivary gland epithelial cells were negatively associated with elevated miR-146a expression. Therefore, this study provides the first indication that salivary gland epithelial cells may be critically involved in SjS progression by altering CD86:CD80 protein ratio in response to miR-146a upregulation.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD80; Co-stimulation; Epithelial cells; Salivary glands; Sjögren’s syndrome; miR-146a; microRNA

Mesh:

Substances:

Year:  2015        PMID: 26505653      PMCID: PMC4679674          DOI: 10.1016/j.molimm.2015.09.027

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  43 in total

1.  Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells.

Authors:  Claire N Manzotti; Helen Tipping; Laura C A Perry; Karen I Mead; Patrick J Blair; Yong Zheng; David M Sansom
Journal:  Eur J Immunol       Date:  2002-10       Impact factor: 5.532

Review 2.  What's the difference between CD80 and CD86?

Authors:  David M Sansom; Claire N Manzotti; Yong Zheng
Journal:  Trends Immunol       Date:  2003-06       Impact factor: 16.687

3.  CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells.

Authors:  Yong Zheng; Claire N Manzotti; Michael Liu; Fiona Burke; Karen I Mead; David M Sansom
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

4.  Treatment with anti-CD86 costimulatory molecule prevents the autoimmune lesions in murine Sjögren's syndrome (SS) through up-regulated Th2 response.

Authors:  K Saegusa; N Ishimaru; K Yanagi; N Haneji; M Nishino; M Azuma; I Saito; Y Hayashi
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

5.  Glandular and extraglandular expression of costimulatory molecules in patients with Sjögren's syndrome.

Authors:  R Matsumura; K Umemiya; T Goto; T Nakazawa; M Kagami; H Tomioka; E Tanabe; T Sugiyama; M Sueishi
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

6.  Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4.

Authors:  E K Kapsogeorgou; H M Moutsopoulos; M N Manoussakis
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

7.  Minor salivary gland involvement in Sjögren's syndrome.

Authors:  T M Tarpley; L G Anderson; C L White
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1974-01

Review 8.  AU-rich elements: characterization and importance in mRNA degradation.

Authors:  C Y Chen; A B Shyu
Journal:  Trends Biochem Sci       Date:  1995-11       Impact factor: 13.807

Review 9.  Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: an update.

Authors:  S Cha; A B Peck; M G Humphreys-Beher
Journal:  Crit Rev Oral Biol Med       Date:  2002

10.  Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.

Authors:  Seunghee Cha; Hiroyuki Nagashima; Vinette B Brown; Ammon B Peck; Michael G Humphreys-Beher
Journal:  Arthritis Rheum       Date:  2002-05
View more
  4 in total

1.  Relationship of miRNA-146a to primary Sjögren's syndrome and to systemic lupus erythematosus: a meta-analysis.

Authors:  Hong-Yan Sun; An-Kun Lv; Hua Yao
Journal:  Rheumatol Int       Date:  2017-06-01       Impact factor: 2.631

Review 2.  MicroRNAs in Autoimmunity and Hematological Malignancies.

Authors:  Mirco Di Marco; Alice Ramassone; Sara Pagotto; Eleni Anastasiadou; Angelo Veronese; Rosa Visone
Journal:  Int J Mol Sci       Date:  2018-10-12       Impact factor: 5.923

3.  Analysis of differentially expressed microRNA of TNF-α-stimulated mesenchymal stem cells and exosomes from their culture supernatant.

Authors:  Hualin Ma; Shuyan Zhang; Ying Xu; Rongrong Zhang; Xinzhou Zhang
Journal:  Arch Med Sci       Date:  2017-10-20       Impact factor: 3.318

4.  Leptin/OB-R pathway promotes IL-4 secretion from B lymphocytes and induces salivary gland epithelial cell apoptosis in Sjögren's syndrome.

Authors:  Ting Xu; Wen Xie; Yingchun Ma; Shiliang Zhou; Lu Zhang; Jinyun Chen; Mingyuan Cai; Rurong Sun; Peirong Zhang; Shaobo Yu; Zheng Xu; Wanlan Jiang; Min Wu
Journal:  Oncotarget       Date:  2017-06-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.